← Evidence map

ArticleMedicina (Kaunas, Lithuania)2026

C-Peptide Changes and Glycemic Response During DPP-4 Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: The Role of Baseline C-Peptide.

İrfan Alişan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

C-Peptide Changes and Glycemic Response During DPP-4 Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: The Role of Baseline C-Peptide. | OpenQuestion